BridgeBio Pharma, Inc.
Genetic-disease biopharma with commercial ATTR therapy and multiple targeted late-stage precision medicines.
Genetic & rare disease · Small molecules and precision genetic medicines · Commercial + NDA submitted
Genetic-disease biopharma with commercial ATTR therapy and multiple targeted late-stage precision medicines.
Genetic & rare disease · Small molecules and precision genetic medicines · Commercial + NDA submitted